The clinical team should monitor blood pressure, heart rate, and hemoglobin are advised in patients treated with vericiguat.

Monitor BNP or NT-proBNP levels to assess response to the therapy to vericiguat. Monitor fluid intake and output, body weight, and clinical signs and symptoms of congestion and hypoperfusion in patients with heart failure.